The following is from Becker’s Hospital Review. The U.S. has an all-time record number of actively licensed nurses — 5.6 million — but hospitals are struggling to recruit and retain enough. To discover missed opportunities, researchers surveyed 7,887 nurses who […]
The following is from Becker’s Hospital Review. A number of healthcare organizations have recently closed medical departments or ended services at facilities to shore up finances, focus on more in-demand services or address staffing shortages. Here are 20 department closures
20 US hospitals making cuts or closing departments Read More »
The following is from Natural News. A report has found that nearly six in 10 doctors in the United States received payments from Big Pharma firms between 2013 and 2022. This is according to a study done by researchers at Pennsylvania State University, which found
The following is from KFF Health News. When the FDA recently convened a committee of advisers to assess a cardiac device made by Abbott, the agency didn’t disclose that most of them had received payments from the company or conducted
10 doctors on FDA panel reviewing Abbott heart device had financial ties with company Read More »
For whatever reason, America’s health officials haven’t seemed publicly interested in answering a crucial question: How many illnesses and deaths can be attributed to COVID versus the vaccines or some combination? Today, we look at shocking and graphic evidence that
The COVID experience ignited a movement within mainstream medicine among doctors who say their institutions or the government barred them from helping their patients. Hundreds of like-minded medical professionals recently gathered in Phoenix, Arizona for a third annual conference, where
In recent days, Colorado Representative Lauren Boebert announced she had emergency surgery for a blood clot and was diagnosed with an iliac vein problem called May-Thurner syndrome. Though it’s impossible to know the root cause, we’ve been reporting on a
The following is from Public Citizen. Amylyx Pharmaceuticals said on Thursday that it would withdraw AMX0035 (sodium phenylbutyrate and taurursodiol, sold as Relyvrio) from the market. A large clinical trial recently found that the drug did not provide any benefit to patients
Drug manufacturer Amylyx pulls ALS drug Relyvrio from market, citing lack of efficacy Read More »
